scholarly journals Factors associated with switching from sulfonylureas to dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in the United States

2021 ◽  
Author(s):  
Xi Tan ◽  
Lingfeng Yang ◽  
Kamlesh Khunti ◽  
Ruya Zhang ◽  
Ye Zhang ◽  
...  
Keyword(s):  
United States ◽  
Type 2 Diabetes ◽  
The United States ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Factors Associated ◽  
Dipeptidyl Peptidase 4 Inhibitors

Impact of Switching from Sulfonylureas to Dipeptidyl Peptidase-4 Inhibitors on Hypoglycemia Burden in the United States—A Predictive Modeling Approach

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 385-P
Author(s):  
JINAN LIU ◽  
YUEXIN TANG ◽  
HAKIMA HANNACHI ◽  
SAMUEL S. ENGEL ◽  
SWAPNIL RAJPATHAK
Keyword(s):  
United States ◽  
Predictive Modeling ◽  
The United States ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Modeling Approach ◽  
Dipeptidyl Peptidase 4 Inhibitors

scholarly journals Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study

2014 ◽  
Vol 51 (6) ◽  
pp. 1015-1023 ◽  
Author(s):  
Seoyoung C. Kim ◽  
Robert J. Glynn ◽  
Jun Liu ◽  
Brendan M. Everett ◽  
Allison B. Goldfine
Keyword(s):  
Type 2 Diabetes ◽  
Cohort Study ◽  
Cardiovascular Events ◽  
Dipeptidyl Peptidase ◽  
Dipeptidyl Peptidase 4 ◽  
Dipeptidyl Peptidase 4 Inhibitors
Sign in / Sign up

Export Citation Format

Share Document